Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 828

1.

Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern Pennsylvania.

Seaman V, Jumaan A, Yanni E, Lewis B, Neyer J, Roda P, Xu M, Hoffman R.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):534-40. doi: 10.1158/1055-9965.EPI-08-0922. Epub 2009 Feb 3.

PMID:
19190168
[PubMed - indexed for MEDLINE]
Free Article
2.

Validation of the revised 2008 WHO diagnostic criteria in 75 suspected cases of myeloproliferative neoplasm.

Kondo T, Okuno N, Naruse H, Kishimoto M, Tasaka T, Tsujioka T, Matsuoka A, Sugihara T, Tohyama Y, Tohyama K.

Leuk Lymphoma. 2008 Sep;49(9):1784-91. doi: 10.1080/10428190802258972.

PMID:
18661406
[PubMed - indexed for MEDLINE]
3.

The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.

Zhan H, Spivak JL.

Clin Adv Hematol Oncol. 2009 May;7(5):334-42. Review.

PMID:
19521323
[PubMed - indexed for MEDLINE]
4.

A multidisciplinary investigation of a polycythemia vera cancer cluster of unknown origin.

Seaman V, Dearwent SM, Gable D, Lewis B, Metcalf S, Orloff K, Tierney B, Zhu J, Logue J, Marchetto D, Ostroff S, Hoffman R, Xu M, Carey D, Erlich P, Gerhard G, Roda P, Iannuzzo J, Lewis R, Mellow J, Mulvihill L, Myles Z, Wu M, Frank A, Gross-Davis CA, Klotz J, Lynch A, Weissfeld J, Weinberg R, Cole H.

Int J Environ Res Public Health. 2010 Mar;7(3):1139-52. doi: 10.3390/ijerph7031139. Epub 2010 Mar 17.

PMID:
20617023
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols.

Brubaker LH, Wasserman LR, Goldberg JD, Pisciotta AV, McIntyre OR, Kaplan ME, Modan B, Flannery J, Harp R.

Am J Hematol. 1984 May;16(4):367-73.

PMID:
6720682
[PubMed - indexed for MEDLINE]
6.

Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.

Anía BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ 3rd.

Am J Hematol. 1994 Oct;47(2):89-93.

PMID:
8092146
[PubMed - indexed for MEDLINE]
7.

JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?

Verstovsek S, Silver RT, Cross NC, Tefferi A.

Leukemia. 2006 Nov;20(11):2067. Epub 2006 Aug 31. No abstract available.

PMID:
16990780
[PubMed - indexed for MEDLINE]
8.

Familial polycythemia vera.

Miller RL, Purvis JD 3rd, Weick JK.

Cleve Clin J Med. 1989 Nov-Dec;56(8):813-8. Review.

PMID:
2691118
[PubMed - indexed for MEDLINE]
9.

[A clinical and biological study of 33 cases of polycythemia vera].

Corredoira JC, González M, Pérez R, Casariego E, López MJ, García JF, Arias J.

Rev Clin Esp. 1990 May;186(8):378-82. Spanish.

PMID:
2236766
[PubMed - indexed for MEDLINE]
10.

An inhibitor of Janus kinase 2 prevents polycythemia in mice.

Mathur A, Mo JR, Kraus M, O'Hare E, Sinclair P, Young J, Zhao S, Wang Y, Kopinja J, Qu X, Reilly J, Walker D, Xu L, Aleksandrowicz D, Marshall G, Scott ML, Kohl NE, Bachman E.

Biochem Pharmacol. 2009 Aug 15;78(4):382-9. doi: 10.1016/j.bcp.2009.04.025. Epub 2009 May 3.

PMID:
19413997
[PubMed - indexed for MEDLINE]
11.

JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera.

Röthlisberger B, Huber A, Bargetzi M, Mendez A, Heizmann M.

Leuk Lymphoma. 2008 Mar;49(3):586-8. doi: 10.1080/10428190701861652. No abstract available.

PMID:
18297539
[PubMed - indexed for MEDLINE]
12.

Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: report of a new mutation.

Bernardi M, Ruggeri M, Albiero E, Madeo D, Rodeghiero F.

Am J Hematol. 2009 Apr;84(4):258-60. doi: 10.1002/ajh.21357. No abstract available.

PMID:
19229983
[PubMed - indexed for MEDLINE]
13.

Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Vannucchi AM, Masala G, Antonioli E, Chiara Susini M, Guglielmelli P, Pieri L, Maggi L, Caini S, Palli D, Bogani C, Ponziani V, Pancrazzi A, Annunziato F, Bosi A.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2068-73. doi: 10.1158/1055-9965.EPI-09-0353. Epub 2009 Jun 16.

PMID:
19531676
[PubMed - indexed for MEDLINE]
Free Article
14.

Diagnosis of polycythemia vera in an anemic patient.

Hassoun H, Pavlovsky M, Mansoor S, Stopka T.

South Med J. 2000 Jul;93(7):710-2.

PMID:
10923962
[PubMed - indexed for MEDLINE]
15.

Congenital erythrocytosis and polycythemia vera in childhood and adolescence.

Cario H, Schwarz K, Debatin KM, Kohne E.

Klin Padiatr. 2004 May-Jun;216(3):157-62.

PMID:
15175960
[PubMed - indexed for MEDLINE]
16.

Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study.

Remacha AF, Montserrat I, Santamaria A, Oliver A, Barceló MJ, Parellada M.

Haematologica. 1997 Jul-Aug;82(4):406-10.

PMID:
9299851
[PubMed - indexed for MEDLINE]
Free Article
17.

Epidemiology of polycythemia vera in Cte d'Or (Burgundy).

Carli PM.

Nouv Rev Fr Hematol. 1994 Apr;36(2):147-9.

PMID:
8036130
[PubMed - indexed for MEDLINE]
18.

Polycythemia vera and other primary polycythemias.

Prchal JT.

Curr Opin Hematol. 2005 Mar;12(2):112-6. Review.

PMID:
15725900
[PubMed - indexed for MEDLINE]
19.

Cytogenetic studies in polycythemia vera.

Jarosová M, Indrák K, Dusek J, Kapustová M.

Neoplasma. 1988;35(2):221-8.

PMID:
3374710
[PubMed - indexed for MEDLINE]
20.

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.

Kouroupi E, Zoi K, Parquet N, Zoi C, Kiladjian JJ, Grigoraki V, Vainchenker W, Lellouche F, Marzac C, Schlageter MH, Dosquet C, Scott LM, Fenaux P, Loukopoulos D, Chomienne C, Cassinat B.

Br J Haematol. 2008 Aug;142(4):676-9. doi: 10.1111/j.1365-2141.2008.07223.x. Epub 2008 May 22. No abstract available.

PMID:
18503583
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk